| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5889375 | Bone | 2015 | 44 Pages |
Abstract
The superior results obtained with zoledronic acid (ZOLD1, ZOLW1, and ZOLW2) compared to CNT in terms of callus size and resistance could be the consequence of a lower rate of bone turnover at the fracture site due to the anti-catabolic effect of zoledronic acid. Mild suppression of callus remodeling by delayed administration did not impair the initial phase of the fracture healing process.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Y. Hao, X. Wang, L. Wang, Y. Lu, Z. Mao, S. Ge, K. Dai,